3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Gallbladder Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
zanidatamab
1
trametinib
1
pembrolizumab
1
larotrectinib
1
durvalumab
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Biliary Tract Neoplasms
×
zanidatamab
×
Clear all
NCT04466891
2025-09-15
HERIZON-BTC-01
Jazz Pharmaceuticals
Phase 2
Completed
87 enrolled
25 charts
1 FDA